Filing Details
- Accession Number:
- 0001246360-14-002912
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-12 18:07:09
- Reporting Period:
- 2014-06-11
- Filing Date:
- 2014-06-12
- Accepted Time:
- 2014-06-12 17:07:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 911326 | Synageva Biopharma Corp | GEVA | Biological Products, (No Disgnostic Substances) (2836) | 561808663 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532475 | Alan Mark Goldberg | 33 Hayden Ave Lexington MA 02421 | Evp, Medical & Reg. Strategy | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-11 | 1,926 | $0.95 | 2,385 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-06-11 | 18,637 | $8.73 | 21,022 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-06-11 | 1,034 | $0.95 | 22,056 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-11 | 21,597 | $80.00 | 459 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-06-11 | 1,926 | $0.00 | 1,926 | $0.95 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-06-11 | 1,034 | $0.00 | 1,034 | $0.95 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-06-11 | 18,637 | $0.00 | 18,637 | $8.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-07-01 | No | 4 | M | Direct | |
| 0 | 2019-12-15 | No | 4 | M | Direct | |
| 49,066 | 2021-09-22 | No | 4 | M | Direct |
Footnotes
- The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 10, 2014.
- The stock option granted the reporting person an option to purchase 13,202 Shares. 25% of such Shares vested and became exercisable on 07/01/2010, and 1/36 of the remainder of such Shares vested and became exercisable monthly thereafter.
- The stock option granted the reporting person an option to purchase 4,125 Shares. 25% of such Shares vested and became exercisable on 12/15/2010, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter.
- The Stock Option granted the reporting person an option to purchase 88,703 shares of Common Stock (the "Shares"). 25% of the Shares vested and became exercisable on 09/06/2012, and 1/36 of the remainder of the Shares vest and become exercisable monthly thereafter.
Billionaire Hedge Funds
